Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Circulation|July 28, 2004
Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout miceSven Wassmann, Thomas Czech, Martin van Eickels, et al.British Journal of Pharmacology|September 12, 2003
17 Beta-estradiol regulates the expression of endothelin receptor type B in the heartSimone Nuedling, Martin van Eickels, Axel Alléra, et al.European Journal of Heart Failure|June 1, 2005
The influence of oestrogen-deficiency and ACE inhibition on the progression of myocardial hypertrophy in spontaneously hypertensive ratsMartin van Eickels, Rolf Schreckenberg, Pieter A Doevendans, et al.American Journal of Physiology. Heart and Circulatory Physiology|September 2, 2008
Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stressZongmin Zhou, Anastasia Pyriochou, Anastasia Kotanidou, et al.Cardiovascular Research|February 28, 2002
Estrogenic hormone action in the heart: regulatory network and functionFawzi A Babiker, Leon J De Windt, Martin van Eickels, et al.Vascular Health and Risk Management|August 2, 2014
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillationA John Camm, Pierre Amarenco, Sylvia Haas, et al.Journal of the American Heart Association|February 22, 2020
Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With RivaroxabanPaulus Kirchhof, Sylvia Haas, Pierre Amarenco, et al.American Heart Journal|August 10, 2016
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)Gregory Y H Lip, Christoph Hammerstingl, Francisco Marin, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 11, 2017
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS studyA John Camm, Alexander G G Turpie, Susanne Hess, et al.Circulation|November 21, 2007
Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophyDerk Frank, Christian Kuhn, Martin van Eickels, et al.Pageof 6